EN
抗体药类似物
Research Grade Lacnotuzumab
All
TD-HY515016_1.jpg
TD-HY515016_2.jpg
  • CatalogTD-HY515016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsMCS-110, CAS: 1831128-32-5
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Lacnotuzumab


Catalog No. TD-HY515016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target CSF1, Macrophage colony-stimulating factor 1, CSF-1, Lanimostim, M-CSF, MCSF
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P09603
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names MCS-110, CAS: 1831128-32-5
Background Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis.
Note For research use only. Not suitable for clinical or therapeutic use.

 

TD-HY515016_1.jpg
Bioactivity
 
Detects Human CSF1/M-CSF in indirect ELISAs.
TD-HY515016_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Lacnotuzumab.